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The sarcoglycan complex (SGC) is a multimember transmembrane complex inter-
acting with other member of dystrophin-glycoprotein complex (DGC) in order to 
provide a mechano-signaling connection from the cytoskeleton to the extracellular 
matrix in myocytes. Previous investigations have demonstrated that in skeletal and 
cardiac muscle, the SGC is a heterotetrameric unit constituted by the alfa, beta, gam-
ma and delta-sarcoglycans. Other authors demonstrated that the expression of alfa-
sarcoglycan is restricted to striated muscle cells, whereas epsilon-sarcoglycan, is also 
expressed in several other tissues. Moreover, further analysis showed the presence, in 
vascular and visceral smooth muscle, of other sarcoglycan subcomplex,  consisting of 
epsilon, beta, gamma and delta-sarcoglycan, associated with sarcospan.
In order to verify composition of sarcoglycan subcomplex in other tissues, we ana-
lyzed glandular epithelium of prostate, testing it both in normal and in pathological 
conditions. In particular we performed immunoﬂ uorescence reactions using all sar-
coglycans alfa, beta, gamma, delta and epsilon) on biopsies  of ten normal subjects, 
and ten subjects with prostatic hyperplasia and prostatic cancer. Our results showed 
that in normal prostate all tested sarcoglycan are detectable both in epithelial and 
in myoepithelial cells; whereas in biopsies of prostatic hyperplasia all sarcoglycans 
were less detectable, whereas in prostatic carcinoma they were almost absent in both 
cell types. These data demonstrated that also in epithelium of prostate, as well as in 
all epithelia previously tested by us, the sarcoglycan subcomplex play a key role in 
mediating the signalling between cell and extracellular matrix; moreover, the absence 
of all sarcoglycans in pathological glandular tissue, and in particular in mioepithelial 
cells, demonstrated that this glycoprotein can play an important role in signalling for 
contraction of these cells. 
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